课题基金 / 基金详情

EFFECT OF HEMATOPOIETIC CYTOKINES ON RHESUS MONKEY MODEL OF AIDS

EFFECT OF HEMATOPOIETIC CYTOKINES ON RHESUS MONKEY MODEL OF AIDS
造血细胞因子对恒河猴艾滋病模型的影响
批准号:
5219871
负责人:
CHRISTOPHER D HILLYER
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

CHRISTOPHER D HILLYER的其他基金

相似基金

相关文献

中文摘要
翻译
SPID编号:16 贫血、粒细胞减少和血小板减少在HIV患者中很常见。 感染,虽然他们的发病机制还不是很清楚。骨髓 增殖不足(无效的造血)很可能是主要的 导致这些血液学异常的原因,可能是 由于干细胞感染或基质细胞感染导致的 良好的微环境支持骨髓生长。这种增长 是一个复杂的过程,需要初级和次级菌落刺激 因子、营养素和细胞接触。此外,有毒的, 抑制,免疫因素不能存在,如果是最佳的 预计会有造血功能。在对感染SIV的恒河猴的研究中, 我们描述了外周血细胞减少症、分期相关的CFU-GM和 BFU-E低增殖,CD34+祖细胞无感染, 大剂量IL-3和GM-CSF部分恢复CFU生长; HIV分泌的恒河猴骨髓抑制物的存在 感染H9细胞。这些数据显示了感染SIV病毒的相似性 猴子对感染艾滋病毒的人类来说,暗示着无效的造血, 有细胞动力学和可能的抑制性异常,是一个因素 支持使用该模型来研究细胞因子的作用 行政管理。在此,我们建议对 外源性细胞因子对血液学和病毒学的影响 实验感染SIV的恒河猴给药。这 模型是有利的,因为它1)允许对动物进行测试(没有 伴随的抗病毒治疗),2)让调查人员知道时间 感染,3)有明确的疾病进展,4)是 初步数据表明血液学上的 SIV感染的后果与HIV非常相似。 具体地说,我们将研究外源性给药的影响 细胞因子对造血室扩张、细胞位置的影响 感染、病毒复制和细胞因子后的负担 行政管理。我们将利用隔室特异性细胞因子,进行测试 感染淋巴细胞或单核细胞的猴子中SIV占优势 紧张。预计,通过这些目标,将产生积极影响 感染SIV的猕猴体内的细胞因子可以被证明,任何不适 细胞因子对病毒复制的影响是可以阐明的,并且一个模型 可用于未来的细胞因子、骨髓运输和 基因治疗实验。
英文摘要
SPID#: 16 Anemia, granulocytopenia, and thrombocytopenia are common in HIV infection though their pathogenesis is not well understood. Bone marrow hypoproliferation (ineffective hematopoiesis) is likely to be a main contributor to the etiology of these hematologic aberrations, and may be due to stem cell infection, or stromal cell infection with loss of a satisfactory microenvironment to support bone marrow growth. This growth is a complex process requiring primary and secondary colony stimulating factors, nutrients, and cellcell contact. In addition, toxic, inhibitory, and immune factors must not be present if optimal hematopoiesis is expected. In studies of SIV infected rhesus macaques, we have described peripheral blood cytopenias, stage-related CFU-GM and BFU-E hypoproliferation, absence of infection in CD34+ progenitors, partial restoration of CFU growth with high doses of IL-3 and GM-CSF, and the presence of an inhibitor of rhesus bone marrow secreted by HIV infected H9 cells. These data show the similarity of SIV infected monkeys to HIV infected humans, suggest that ineffective hematopoiesis, with cytokinetic and possibly inhibitory abnormalities, is a factor and support the use of this model for studying the effects of cytokine administration. Herein, we propose a comprehensive study of the hematologic and virologic consequences of exogenous cytokine administration in rhesus macaques experimentally infected with SIV. This model is advantageous as it 1) allows testing of animals (without concomitant antiviral therapy), 2) allows investigators to know the time of infection, 3) has a well-defined disease progression and 4) is supported by preliminary data which suggest that the hematologic consequences of SIV infection are very similar to those of HIV. Specifically, we will study the effects of exogenously administered cytokines on hematopoietic compartment expansion, sites of cellular infection, and viral replication and burden following cytokine administration. We will utilize compartment specific cytokines, tested in monkeys infected with a lymphocyte or a monocyte predominate SIV strain. It is expected that, through these aims, the positive effects of cytokines in SIV infected macaques can be demonstrated, any untoward effects of cytokines on viral replication can be elucidated, and a model can be characterized for future cytokine, bone marrow transportation, and gene therapy experiments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
  • 批准号:
    8342007
  • 项目类别:
  • 资助金额:
    $12.18万
  • 财政年份:
    2008
  • 负责人:
    CHRISTOPHER D HILLYER
  • 依托单位:
Development of an ABO Incompatibility Stop Device (AISD)
Prevention of transfusion-transmitted CMV in low birth weight infants using CMV..
  • 批准号:
    8342004
  • 项目类别:
  • 资助金额:
    $68.28万
  • 财政年份:
    2008
  • 负责人:
    CHRISTOPHER D HILLYER
  • 依托单位:
Serious Hazards of Transfusion & Cellular Therapies: Mechanisms and Intervention
  • 批准号:
    7502298
  • 项目类别:
  • 资助金额:
    $187.41万
  • 财政年份:
    2008
  • 负责人:
    CHRISTOPHER D HILLYER
  • 依托单位:
海外基金